Previous 10 | Next 10 |
2023-03-21 09:32:47 ET Viatris (NASDAQ: VTRS) makes both generic and branded drugs and its stock looks like a potential steal of a deal at the moment. It trades at less than 6 times its earnings, and it pays a dividend that today yields just over 5%. But when a stock is so heavi...
2023-03-14 06:03:00 ET The collapse of SVB Financial's Silicon Valley Bank last week likely threw a monkey wrench into the macroeconomic machinery that was working to end the current bear market. Investors should expect the market to remain volatile, at least in the near term, as it abs...
2023-03-07 11:05:11 ET Viatris ( NASDAQ: VTRS ) had declared $0.12/share quarterly dividend , in line with previous. Payable March 17; for shareholders of record March 9; ex-div March 8. See VTRS Dividend Scorecard, Yield Chart, & Dividend Growth. For fur...
2023-03-05 11:28:00 ET Teva Pharmaceutical Industries (NYSE: TEVA) and Viatris (NASDAQ: VTRS) are two of the top makers of generic pharmaceuticals, but both healthcare companies are having to look beyond their generic and branded drugs to find a way to grow sales. Wh...
Viatris ( NASDAQ: VTRS ) has become the latest drugmaker to voice opposition to changes to the U.K. voluntary medicines pricing agreement after its U.S. rivals AbbVie ( ABBV ) and Eli Lilly ( LLY ) left the deal early this year, citing strict government requirements. Canonsbur...
Summary Viatris recently closed out 2022 having largely met management's prior guidance. It's aggressively paying down debt and recent acquisitions may drive meaningful growth down the road. It pays a healthy and well-covered starting yield, and share buybacks combined with a low va...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: taffpixture/Shutterstock Intuitive Machines (NASDAQ: LUNR ) stock is climbing higher on Monday thanks to coverage from Canaccord analyst Austin Moeller. That coverage comes with a new buy” rating ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Zigres / Shutterstock.com Warren Buffett and Tesla (NASDAQ: TSLA ) stock are hot topics among traders on Monday following a series of Tweets. The tweet that brought these two topics together comes from Tw...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Postmodern Studio / Shutterstock.com Viatris (NASDAQ: VTRS ) stock is in the news Monday after the healthcare company announced Scott Smith as its next CEO . This will see Smith take over as the next CEO ...
Viatris Inc. (VTRS) Q4 2022 Earnings Conference Call February 27, 2023 08:30 AM ET Company Participants Robert Coury - Executive Chairman Scott Smith - Incoming Chief Executive Officer Michael Goettler - Chief Executive Officer Rajiv Malik - President Sanjeev N...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 12:25:00 ET The late comedian Rodney Dangerfield was famous for his catchphrase, "I don't get no respect." Does Dangerfield's line apply to some stocks today? Absolutely. Three Motley Fool contributors think they've found surprisingly underrated pharmaceutical stocks to b...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...